Sofinnova Venture Partners Viii, L.p. - Net Worth and Insider Trading
Sofinnova Venture Partners Viii, L.p. Net Worth
The estimated net worth of Sofinnova Venture Partners Viii, L.p. is at least $207 Million dollars as of 2024-09-20. Sofinnova Venture Partners Viii, L.p. is the 10% Owner of Principia Biopharma Inc and owns about 2,038,208 shares of Principia Biopharma Inc (PRNB) stock worth over $204 Million. Sofinnova Venture Partners Viii, L.p. is also the 10% Owner of Aclaris Therapeutics Inc and owns about 2,289,480 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $3 Million. Details can be seen in Sofinnova Venture Partners Viii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sofinnova Venture Partners Viii, L.p. has not made any transactions after 2018-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sofinnova Venture Partners Viii, L.p.
Sofinnova Venture Partners Viii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Venture Partners Viii, L.p. owns 7 companies in total, including Principia Biopharma Inc (PRNB) , Aclaris Therapeutics Inc (ACRS) , and Synlogic Inc (SYBX) among others .
Insider Ownership Summary of Sofinnova Venture Partners Viii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2018-09-18 | 10 percent owner |
| ACRS | Aclaris Therapeutics Inc | 2015-10-13 | 10 percent owner |
| SYBX | Synlogic Inc | 2015-09-30 | 10 percent owner |
 | | 2015-01-29 | 10 percent owner |
| | 2014-12-02 | 10 percent owner |
| | 2014-09-11 | 10 percent owner |
| | 2014-03-20 | 10 percent owner |
Sofinnova Venture Partners Viii, L.p. Latest Holdings Summary
Sofinnova Venture Partners Viii, L.p. currently owns a total of 2 stocks. Among these stocks, Sofinnova Venture Partners Viii, L.p. owns 2,038,208 shares of Principia Biopharma Inc (PRNB) as of September 18, 2018, with a value of $204 Million and a weighting of 98.73%. Sofinnova Venture Partners Viii, L.p. also owns 2,289,480 shares of Aclaris Therapeutics Inc (ACRS) as of October 13, 2015, with a value of $3 Million and a weighting of 1.27%.
Latest Holdings of Sofinnova Venture Partners Viii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2018-09-18 | 2,038,208 | 100.05 | 203,922,710 |
| ACRS | Aclaris Therapeutics Inc | 2015-10-13 | 2,289,480 | 1.15 | 2,632,902 |
Holding Weightings of Sofinnova Venture Partners Viii, L.p.
Sofinnova Venture Partners Viii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Sofinnova Venture Partners Viii, L.p. has made a total of 0 transactions in Principia Biopharma Inc (PRNB) over the past 5 years. The most-recent trade in Principia Biopharma Inc is the acquisition of 270,000 shares on September 18, 2018, which cost Sofinnova Venture Partners Viii, L.p. around $5 Million.
According to the SEC Form 4 filings, Sofinnova Venture Partners Viii, L.p. has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 409,090 shares on October 13, 2015, which cost Sofinnova Venture Partners Viii, L.p. around $4 Million.
Insider Trading History of Sofinnova Venture Partners Viii, L.p.
- 1
Sofinnova Venture Partners Viii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Sofinnova Venture Partners Viii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sofinnova Venture Partners Viii, L.p. is 28.88%. GuruFocus also compares Sofinnova Venture Partners Viii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Sofinnova Venture Partners Viii, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sofinnova Venture Partners Viii, L.p.'s insider trading performs compared to the benchmark.
Performance of Sofinnova Venture Partners Viii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.2 | | | | | |
| Relative Return to S&P 500(%) | 14.05 | | | | | |
Sofinnova Venture Partners Viii, L.p. Ownership Network
Sofinnova Venture Partners Viii, L.p. Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Sofinnova Venture Partners Viii, L.p. is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include director & President & CEO Martin Babler , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Sofinnova Venture Partners Viii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Sofinnova Venture Partners Viii, L.p.. You might contact Sofinnova Venture Partners Viii, L.p. via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
